Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Cytomegalovirus (CMV) infections spread through body fluids such as saliva, semen, breast milk, and urine. Signs and symptoms of the infections include, fatigue, fever, diarrhea, pneumonia, and hepatitis, shortness of breath, gastrointestinal ulceration, and bleeding.

Although no treatment for the infection caused by human papillomavirus (HPV) is available, symptoms can be treated. Most sexually active men and women suffer from HPV infections. The infections spread through oral, vaginal or anal sex. HPV can also be transmitted during birth to infant and can lead to genital or respiratory infections.

Market Dynamics

Increasing collaboration activities of major players is expected to propel growth of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market. For instance, in November 2018, GeoVax Labs Inc. announced collaboration with Virometix. The collaboration focuses on development of therapeutic vaccines for HPV infections. This collaboration will include preclinical animal testing of GeoVax's MVA-Vectored HPV vaccines candidates in combination with Virometix synthetic HPV vaccines candidates.

Moreover, increasing regulatory approvals for novel therapies is expected to boost the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market growth. For instance, in November 2021, Merck received the U.S. Food and Drug Administration approval for its Prevymis (letermovir) tablets and intravenous (IV) injection for prophylaxis of CMV infections and CMV seropositive recipients.

Key features of the study:

This report provides in-depth analysis of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market size (US$ Mn), and cumulative annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, , Allergan, Bausch Health, GlaxoSmithKline, Lee's Pharmaceutical Holdings, Merck Sharp & Dohme, Fougera Pharmaceuticals, Clinigen Group plc., Perrigo Company plc., Roche Holding AG, Biotest AG, and Fresenius Kabi
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Drug Type:
HPV Therapeutics
- Immunomodulatory Agents
Interleukins
Cytokines
Chemokine
Others
- Keratolytic Agents
TCA (Trichloroacetic Acid)
Bichloracetic Acid
- Anti-neoplastic Agents
- Sinecatechins
CMV Therapeutics
- Ganciclovir/Valganciclovir
- Foscarnet
- Cidifovir
Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Application:
HPV Therapeutics Application
- Genital warts
- Cervical cancer
- Epidermodysplasia Verrucifdormis
- Others
CMV Therapeutics Application
- CMV Retinitis
- Pneumonia
- Gastrointestinal ulcers
- Encephalitis
- Others
Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Region:
North America
By Country:
- U.S.
- Canada
By Drug Type:
- HPV Therapeutics
Immunomodulatory Agents
Interleukins
Cytokines
Chemokine
Others
Keratolytic Agents
TCA (Trichloroacetic Acid)
Bichloracetic Acid
Anti-neoplastic Agents
Sinecatechins
- CMV Therapeutics
Ganciclovir/Valganciclovir
Foscarnet
Cidifovir
By Application
- HPV Therapeutics Application
Genital warts
Cervical cancer
Epidermodysplasia Verrucifdormis
Others
- CMV Therapeutics Application
CMV Retinitis
Pneumonia
Gastrointestinal ulcers
Encephalitis
Others
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Europe
By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
By Drug Type:
- HPV Therapeutics
Immunomodulatory Agents
Interleukins
Cytokines
Chemokine
Others
Keratolytic Agents
TCA (Trichloroacetic Acid)
Bichloracetic Acid
Anti-neoplastic Agents
Sinecatechins
- CMV Therapeutics
Ganciclovir/Valganciclovir
Foscarnet
Cidifovir
By Application
- HPV Therapeutics Application
Genital warts
Cervical cancer
Epidermodysplasia Verrucifdormis
Others
- CMV Therapeutics Application
CMV Retinitis
Pneumonia
Gastrointestinal ulcers
Encephalitis
Others
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Asia Pacific
By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
By Drug Type:
- HPV Therapeutics
Immunomodulatory Agents
Interleukins
Cytokines
Chemokine
Others
Keratolytic Agents
TCA (Trichloroacetic Acid)
Bichloracetic Acid
Anti-neoplastic Agents
Sinecatechins
- CMV Therapeutics
Ganciclovir/Valganciclovir
Foscarnet
Cidifovir
By Application
- HPV Therapeutics Application
Genital warts
Cervical cancer
Epidermodysplasia Verrucifdormis
Others
- CMV Therapeutics Application
CMV Retinitis
Pneumonia
Gastrointestinal ulcers
Encephalitis
Others
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Latin America
By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
By Drug Type:
- HPV Therapeutics
Immunomodulatory Agents
Interleukins
Cytokines
Chemokine
Others
Keratolytic Agents
TCA (Trichloroacetic Acid)
Bichloracetic Acid
Anti-neoplastic Agents
Sinecatechins
- CMV Therapeutics
Ganciclovir/Valganciclovir
Foscarnet
Cidifovir
By Application
- HPV Therapeutics Application
Genital warts
Cervical cancer
Epidermodysplasia Verrucifdormis
Others
- CMV Therapeutics Application
CMV Retinitis
Pneumonia
Gastrointestinal ulcers
Encephalitis
Others
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Middle East
By Country:
- GCC
- Israel
- Rest of Middle East
By Drug Type:
- HPV Therapeutics
Immunomodulatory Agents
Interleukins
Cytokines
Chemokine
Others
Keratolytic Agents
TCA (Trichloroacetic Acid)
Bichloracetic Acid
Anti-neoplastic Agents
Sinecatechins
- CMV Therapeutics
Ganciclovir/Valganciclovir
Foscarnet
Cidifovir
By Application
- HPV Therapeutics Application
Genital warts
Cervical cancer
Epidermodysplasia Verrucifdormis
Others
- CMV Therapeutics Application
CMV Retinitis
Pneumonia
Gastrointestinal ulcers
Encephalitis
Others
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Africa
By Country/Region:
- South Africa
- Central Africa
- North Africa
By Drug Type:
- HPV Therapeutics
Immunomodulatory Agents
Interleukins
Cytokines
Chemokine
Others
Keratolytic Agents
TCA (Trichloroacetic Acid)
Bichloracetic Acid
Anti-neoplastic Agents
Sinecatechins
- CMV Therapeutics
Ganciclovir/Valganciclovir
Foscarnet
Cidifovir
By Application
- HPV Therapeutics Application
Genital warts
Cervical cancer
Epidermodysplasia Verrucifdormis
Others
- CMV Therapeutics Application
CMV Retinitis
Pneumonia
Gastrointestinal ulcers
Encephalitis
Others
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Company Profiles
GlaxoSmithKline*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Allergan
Bausch Health
Lee's Pharmaceutical Holdings
Merck Sharp & Dohme
Fougera Pharmaceuticals
Clinigen Group plc.
Perrigo Company plc.
Roche Holding AG
Biotest AG
Fresenius Kabi

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2707

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Epidemiology
Technology Advancements
Patent Analysis
Adherence Rate
Product Switch (U.S.)
Historical Overview
Merger and Acquisition
Regulatory and Reimbursement Scenario
PORTER'S Five Forces
PEST Analysis

4. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market By Drug Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
HPV Therapeutics
- Immunomodulatory Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Interleukins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cytokines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Chemokine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Keratolytic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- TCA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Bichloracetic Acid
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Anti-neoplastic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Sinecatechins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
CMV Therapeutics
- Ganciclovir/ Valaganciclovir
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Foscarnet
- Introduction
- Market Size and Forecast , and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cidifovir
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market, By Application, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
HPV Therapeutics Application
- Genital warts
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cervical cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Epidermodysplasia Verrucifdormis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
CMV Therapeutics Application
- CMV Retinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Pneumonia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Gastrointestinal ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Encephalitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market, By Distribution Chanel, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Market, By Region, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Africa
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- GlaxoSmithKline
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- ALLERGAN
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bausch Health
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Lee's Pharmaceuticals Holdings
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck Sharp & Dohme
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Fougera Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Clinigen Group plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Perrigo Company plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Roche Holdings AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Fresenius Kabi
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact

Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028